CMS has an international R&D team full of experienced professionals with Master degree or above in different fields, including biochemistry, immunology, chemistry, medicine, and pharmacy, etc. Among them, there are 4 doctors of immunology, organic synthesis, clinical medicine, 20 masters and a senior engineer of medicine and pharmacy, a doctor of biology graduated from Hong Kong University, a doctor graduated from Berlin University of Germany with the majority of reproductive toxic, a doctor of the pharmaceutical project obtained in Germany and so on. Now our own R&D team is mainly consisted of two parts in details:

P. R. China
1. Kangzhe Pharmaceutical Research & Development (Shenzhen) Ltd.
Being concentrating on the research and development of new drugs apart from chemical compounds
2. Hunan Kangzhe Zhongnan Research & Development Ltd.
Be responsible for the research and development of biological products

Overseas
1. CMS Peptides Patent Holding Company Limited (B. V. I)
2. CrossPac Group Limited (B. V. I)
The three overseas companies are concentrating their efforts in developing the new drugs in the international markets including related studies of experiments and development of markets.